Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies.

MLA

Okimoto, Kenichiro, et al. “Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter Pylori after Failures of First- and Second-Line Therapies.” International Scholarly Research Notices, vol. 2014, Dec. 2014, p. 631501. EBSCOhost, https://doi.org/10.1155/2014/631501.

APA

Okimoto, K., Arai, M., Saito, K., Minemura, S., Maruoka, D., Matsumura, T., Nakagawa, T., Katsuno, T., Ishii, C., Murata, S., Watanabe, M., Nomura, F., & Yokosuka, O. (2014). Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies. International Scholarly Research Notices, 2014, 631501. https://doi.org/10.1155/2014/631501

Chicago

Okimoto, Kenichiro, Makoto Arai, Keiko Saito, Shoko Minemura, Daisuke Maruoka, Tomoaki Matsumura, Tomoo Nakagawa, et al. 2014. “Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter Pylori after Failures of First- and Second-Line Therapies.” International Scholarly Research Notices 2014 (December): 631501. doi:10.1155/2014/631501.